Evaluation in Nonhuman Primates of Vaccines against Ebola Virus-Reference-Cited by-同舟云学术

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus

Published:2002-05 Issue:5 Volume:8 Page:503-507
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Geisbert Thomas W.¹,Pushko Peter¹,Anderson Kevin¹,Smith Jonathan¹,Davis Kelly J.¹,Jahrling Peter B.¹

Affiliation:

1. U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference30 articles.

1. Sanchez A, Khan AS, Zaki SR, Nabel GJ, Ksiazek TG, Peters CJ. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, et al., editors. Fields virology. Philadelphia: Lippincott-Raven Publishers, 2001. p. 1279-304.

2. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.;Georges-Courbot;Emerg Infect Dis,1997

3. Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001.;World Health Organization;Wkly Epidemiol Rec,2001

4. Preliminary report: isolation of Ebola virus from monkeys imported to the USA.;Jahrling;Lancet,1990

5. Inactivated vaccine for Ebola virus efficacious in guinea pig model.;Lupton;Lancet,1980

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses;Expert Opinion on Drug Discovery;2024-08-18

2. Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory;Virologica Sinica;2024-06

3. A Glass-Half-Full Perspective on Negative Data in Ebolavirus Vaccine Studies;The Journal of Infectious Diseases;2024-03-15

4. Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses;Viruses;2024-03-10

5. Vaccine against RNA viruses;Bioreactor Design Concepts for Viral Vaccine Production;2024